A detailed history of Chiron Capital Management, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Chiron Capital Management, LLC holds 27,950 shares of PGEN stock, worth $41,086. This represents 0.04% of its overall portfolio holdings.

Number of Shares
27,950
Previous 24,050 16.22%
Holding current value
$41,086
Previous $32,000 25.0%
% of portfolio
0.04%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.21 - $1.75 $4,719 - $6,825
3,900 Added 16.22%
27,950 $40,000
Q4 2023

Feb 12, 2024

SELL
$0.89 - $1.41 $28,302 - $44,838
-31,800 Reduced 56.94%
24,050 $32,000
Q3 2023

Nov 14, 2023

BUY
$1.08 - $1.85 $10,739 - $18,396
9,944 Added 21.66%
55,850 $79,000
Q2 2023

Jul 27, 2023

SELL
$0.96 - $1.4 $714 - $1,041
-744 Reduced 1.59%
45,906 $52,000
Q1 2023

Apr 21, 2023

SELL
$0.88 - $2.19 $20,106 - $50,037
-22,848 Reduced 32.88%
46,650 $49,000
Q4 2022

Jan 23, 2023

BUY
$1.27 - $2.26 $29,491 - $52,481
23,222 Added 50.18%
69,498 $0
Q3 2022

Oct 13, 2022

SELL
$1.41 - $2.79 $4,935 - $9,765
-3,500 Reduced 7.03%
46,276 $98,000
Q2 2022

Jul 25, 2022

SELL
$1.15 - $2.53 $25,036 - $55,080
-21,771 Reduced 30.43%
49,776 $67,000
Q1 2022

Apr 18, 2022

BUY
$1.91 - $3.98 $1,665 - $3,470
872 Added 1.23%
71,547 $151,000
Q4 2021

Jan 18, 2022

SELL
$3.53 - $5.5 $16,117 - $25,113
-4,566 Reduced 6.07%
70,675 $262,000
Q3 2021

Oct 21, 2021

BUY
$4.99 - $6.55 $30,439 - $39,955
6,100 Added 8.82%
75,241 $375,000
Q2 2021

Jul 20, 2021

BUY
$6.24 - $8.22 $29,328 - $38,634
4,700 Added 7.29%
69,141 $451,000
Q1 2021

May 18, 2021

BUY
$6.74 - $10.95 $2,696 - $4,380
400 Added 0.62%
64,441 $444,000
Q4 2020

Mar 05, 2021

BUY
$3.75 - $10.56 $70,125 - $197,472
18,700 Added 41.24%
64,041 $653,000
Q3 2020

Nov 19, 2020

BUY
$3.5 - $6.2 $158,693 - $281,114
45,341 New
45,341 $159,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $306M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Chiron Capital Management, LLC Portfolio

Follow Chiron Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Capital Management, LLC with notifications on news.